The first effects of the arrival of the European Medicines Agency EMA are already being felt.
The EMA effect is also good news for scientific research. Director Bart Klijsen of IXA VU-VUmc says, “In order to bring research to society, cooperation and participation with companies is indispensable. This requires a mature ecosystem. That is why the arrival of EMA is positive for the Netherlands and for the region. Although not all contacts are directly related to EMA, there is a lot more interest from the medical industry in Amsterdam.”
Read the full Parool article of Herman Stil, Artikel-Parool-Als-EMA-over-de-dam-is…..pdf
UvA professors Cees Snoek and Marcel Worring are starting a new public-private research lab together with researchers from the Inception Institute of Artificial Intelligence Ltd. from the United Arab Emirates led by Professor Ling Shao. Within the new AIM lab, the researchers will focus on using artificial intelligence for medical image analysis. The lab will […]News
Azafaros, a biotech company established in Leiden in the Netherlands, focusing on the development of new therapies in the field of rare metabolic disorders, announced the closing of a seed financing round. BioGeneration Ventures (BGV) is the founding investor. Rare metabolic disorders such as lysosomal storage disorders (LSDs) represent a broad class of severe and […]News
Artistic and scientific research combined into an exciting artwork at new VU-based ArtScience labora-tory Hybrid Forms Lab. GAMeC, the prestigious Italian art museum, acquires artwork from artists Evelina Domnitch and Dmitry Gelfand; artists are based at the VU physics & astronomy department Hybrid Forms laboratory, part of the Demonstrator Lab. The ArtScience Laboratory of the […]News